We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Maxygen Expects to File IND for Hepatitis Treatments in 2006
Maxygen Expects to File IND for Hepatitis Treatments in 2006
April 1, 2005
Maxygen and Roche are completing late-stage preclinical studies and manufacturing on their collaborative effort to develop improved interferon alpha protein therapeutics to treat hepatitis C virus (HCV) and hepatitis B virus (HBV) infections, and they expect to file an investigational new drug application toward Phase I clinical trials next year, Maxygen said.